Markers of inflammation and influence of nitric oxide on platelet activation in the course of ulcerative colitis

被引:13
作者
Gawronska, Beata [1 ]
Matowicka-Karna, Joanna [1 ]
Kralisz, Maciej [2 ]
Kemona, Halina [1 ]
机构
[1] Med Univ Bialystok, Dept Clin Lab Diagnost, Bialystok, Poland
[2] Sniadecki Reg Hosp Bialystok, Dept Internal Dis & Gastroenterol, Bialystok, Poland
关键词
ulcerative colitis; platelet activation; nitric oxide; MMP-9; IL-6; BOWEL-DISEASE; BLOOD-PLATELETS; CROHNS-DISEASE; P-SELECTIN; INHIBITION; MECHANISMS; NEOPTERIN; MATRIX-METALLOPROTEINASE-9; AGGREGATION; ADHESION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Ulcerative colitis is a non-specific inflammatory bowel disease of unknown etiology. We investigated whether severe form of ulcerative colitis may lead to increased number of platelets, changes in platelet parameters and their activation. To address our objectives, we measured concentrations of nitric oxide and markers of inflammation. We found increased number of low-volume platelets in a group of affected patients. However, their activity was not as high as expected. In addition to that we observed eight times higher concentration of nitric oxide in patients suffering from ulcerative colitis than in healthy individuals. Besides, severe form of the disease manifested itself with increased concentrations of interleukine 6, matrix metalloproteinase-9 and neopterin. Based on the results we propose that high amounts of nitric oxide inhibit platelet activation in severe form of ulcerative colitis. Moreover, our observations regarding interleukine 6, matrix metalloproteinase-9 and neopterin suggest that they may become useful markers of active form of ulcerative colitis.
引用
收藏
页码:68108 / 68114
页数:7
相关论文
共 46 条
[1]
Fecal MMP-9: A New Noninvasive Differential Diagnostic and Activity Marker in Ulcerative Colitis [J].
Annahazi, Anita ;
Molnar, Tamas ;
Farkas, Klaudia ;
Rosztoczy, Andras ;
Izbeki, Ferenc ;
Gecse, Krisztina ;
Inczefi, Orsolya ;
Nagy, Ferenc ;
Foeldesi, Imre ;
Szucs, Monika ;
Dabek, Marta ;
Ferrier, Laurent ;
Theodorou, Vassilia ;
Bueno, Lionel ;
Wittmann, Tibor ;
Roka, Richard .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) :316-320
[2]
Avdagic N, 2013, BOSNIAN J BASIC MED, V13, P5
[3]
Bartold M, 2015, DIAGN LAB, V51, P153
[4]
Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro [J].
Bode-Böger, SM ;
Böger, RH ;
Galland, A ;
Frölich, JC .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (02) :143-150
[5]
Environmental risk factors in Crohn's disease and ulcerative colitis: an update [J].
Carbonnel, F. ;
Jantchou, P. ;
Monnet, E. ;
Cosnes, J. .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 :S145-S157
[6]
Ciecko-Michalska Irena, 2010, Przegl Lek, V67, P1262
[7]
Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis [J].
Garg, Pallavi ;
Vijay-Kumar, Matam ;
Wang, Lixin ;
Gewirtz, Andrew T. ;
Merlin, Didier ;
Sitaraman, Shanthi V. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (02) :G175-G184
[8]
Guclu M, 2010, EUR J GEN MED, V7, P259
[9]
Neopterin Concentration as an Index of Disease Activity in Crohn's Disease and Ulcerative Colitis [J].
Husain, Nisreen ;
Tokoro, Ken ;
Popov, Joanna M. ;
Naides, Stanley J. ;
Kwasny, Mary J. ;
Buchman, Alan L. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (03) :246-251
[10]
Biomarkers in inflammatory bowel disease: current practices and recent advances [J].
Iskandar, Heba N. ;
Ciorba, Matthew A. .
TRANSLATIONAL RESEARCH, 2012, 159 (04) :313-325